跳至主要内容
临床试验/TCTR20240701005
TCTR20240701005已完成不适用

The Role Of Serum Prolidase Activity, Matrix Metalloproteinase-1, Matrix Metalloproteinase-7, Transforming growth factor-beta Values In Prediction Of Early Fibrosis In Patients With Moderate And Severe COVID-19

Selcuk University Faculty of Medicine0 个研究点目标入组 68 人开始时间: 2024年7月1日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
68

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18 Years 至 N/A (No limit)(—)
性别
All

入选标准

  • Patients aged 18 years and over who were diagnosed or considered as possible COVID-19.

排除标准

  • 1. Pregnant women,
  • 2. Patients under 18 years of age,
  • 3. Patients with pre-existing interstitial lung disease (ILD),
  • 4. Patients with malignancy,
  • 5. Patients who did not sign a consent form were excluded from the study.

研究者

发起方
Selcuk University Faculty of Medicine

相似试验